| 摘要 |
The present invention provides the use of IFN-.alpha. in association with Amantadine for the manufacture of medicaments for the treatment of chronic hepatitis C infections. The present invention also provides medicaments containing the IFN-.alpha. and Amantadine as a combined preparation for simultaneous, separate or sequential use in therapy of chronic hepatitis C infections. The present invention further provides a method for treating chronic hepatitis C infections in patients in need of such treating comprising administering an amount of IFN-.alpha. in association with an amount of Amantadine effective to treat hepatitis C.
|
